Bristol Myers Squibb’s Phase III Clinical Trial for Zeposia Fails to Meet Primary Endpoint of Clinical Remission in Crohn Disease

Company says it remains committed to advancing research for immune-mediated diseases and intends to share trial data at a later date.

Source link
#Bristol #Myers #Squibbs #Phase #III #Clinical #Trial #Zeposia #Fails #Meet #Primary #Endpoint #Clinical #Remission #Crohn #Disease